|
|
|
Insider
Information: |
Alam John J |
Relationship: |
CEO & President, Direc... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
866,331 |
|
Indirect Shares
|
737,179 |
|
|
Direct
Value |
$65,884,842 |
|
|
Indirect Value
|
$2,596,204 |
|
|
Total
Shares |
1,603,510 |
|
|
Total
Value |
$68,481,046 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Med. Dev. Group &... |
2008-10-01 |
136,792 |
2008-10-01 |
5,140 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Cervomed Ord Shs |
CRVO |
CEO & President, Direc... |
2023-11-09 |
729,539 |
2023-11-09 |
732,039 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-09-06 |
4 |
OE |
$18.47 |
$27,705 |
D/D |
1,500 |
195,356 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-10-18 |
4 |
OE |
$18.47 |
$27,705 |
D/D |
1,500 |
105,356 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-08 |
4 |
OE |
$18.47 |
$27,705 |
D/D |
1,500 |
105,356 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-15 |
4 |
OE |
$18.47 |
$27,705 |
D/D |
1,500 |
106,063 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-22 |
4 |
OE |
$18.47 |
$27,705 |
D/D |
1,500 |
106,063 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev., & CMO |
|
2007-01-10 |
4 |
AS |
$35.00 |
$52,500 |
D/D |
(1,500) |
103,376 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev., & CMO |
|
2007-01-31 |
4 |
AS |
$35.46 |
$53,190 |
D/D |
(1,500) |
135,460 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-09-06 |
4 |
AS |
$35.59 |
$53,385 |
D/D |
(1,500) |
103,856 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Product Dev. & CMO |
|
2007-01-24 |
4 |
AS |
$36.20 |
$54,300 |
D/D |
(1,500) |
135,460 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-10-18 |
4 |
AS |
$36.26 |
$54,390 |
D/D |
(1,500) |
103,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-01 |
4 |
OE |
$18.47 |
$55,410 |
D/D |
3,000 |
106,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
|
2007-01-03 |
4 |
AS |
$37.12 |
$55,925 |
D/D |
(1,500) |
103,376 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
|
2006-12-27 |
4 |
AS |
$37.56 |
$56,340 |
D/D |
(1,500) |
103,376 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Drug Eval. & Appr. |
|
2006-12-20 |
4 |
AS |
$37.78 |
$56,670 |
D/D |
(1,500) |
103,376 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev., & CMO |
|
2007-01-17 |
4 |
AS |
$38.29 |
$57,435 |
D/D |
(1,500) |
103,376 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-10-01 |
4 |
OE |
$13.63 |
$57,968 |
D/D |
4,253 |
141,045 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-08 |
4 |
AS |
$41.49 |
$62,235 |
D/D |
(1,500) |
103,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2006-11-29 |
4 |
AS |
$44.21 |
$66,315 |
D/D |
(1,500) |
103,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-22 |
4 |
AS |
$44.36 |
$66,540 |
D/D |
(1,500) |
104,563 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2006-12-06 |
4 |
AS |
$44.69 |
$67,035 |
D/D |
(1,500) |
103,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-08-20 |
4 |
OE |
$10.19 |
$67,376 |
D/D |
6,612 |
143,404 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-08-27 |
4 |
OE |
$10.19 |
$67,376 |
D/D |
6,612 |
143,404 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-09-03 |
4 |
OE |
$10.19 |
$67,376 |
D/D |
6,612 |
143,404 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-09-10 |
4 |
OE |
$10.19 |
$67,397 |
D/D |
6,614 |
143,406 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2006-12-13 |
4 |
AS |
$38.54 |
$76,458 |
D/D |
(1,980) |
101,876 |
0 |
- |
|
68 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|